FDA Investigator Julie A Rorberg
Julie A Rorberg has inspections in 1 countries as of 23 Feb 2022. Julie A Rorberg has collaborated with a combined 1078 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
23 Feb 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amalia C Himaya,
Arie C Menachem,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Binh T Nguyen,
Brian J Ryan,
Brien C Fox,
Bryan A Galvez,
Carla J Lundi,
Carr Sharpe,
Caryn M Everly,
Caryn M Mcnab,
CDR Rochelle B Young, RPh, MSA,
Chelsea N Sealey,
Deborah A Greco,
Donna Mwilliams Hill,
Greg K Keshishyan,
Jalyn M Everly,
Jamie M Du,
Jane S Wernberg,
Jeffrey P Raimondi,
Jennifer M Gogley,
Joey V Quitania,
John A Gonzalez,
Julie A Stocklin,
Julie Rorberg,
Kari M Johansen,
Katherine E Jacobitz,
Kelvin Cheung,
Kelvin X Sanders,
Kim Lthomas Cruse,
Liming Zhang,
Linda Thai,
Ling Yul Liu,
Louis B Cencetti,
Marcus F Yambot,
Matthew J Johnson,
Maxyne T Lam,
Michael D Garcia,
Mihaly S Ligmond,
Nancy L Rolli,
Nicholas L Hunt,
Prasad Peri,
Richard C Chiang,
Rumany C Penn, PharmD,
Saied A Asbagh,
Sarah A Hassas,
Selene T Torres,
Shirnette D Ferguson,
Stephanie A Slater, MS,
Steven E Porter, Jr,
Taichun Qin, PhD,
Tajah L Blackburn,
Tamala P Magee,
Terri L Dodds,
Thao T Kwan,
Thomas J Arista,
Uttaniti Limchumroon (Tom),
Vickie L Anderson,
Virgilio F Pacio, CSO,
Zachary A Bogorad
Julie A Rorberg's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2000 | FDA 483 | Gilead Sciences, Inc. - Form 483, 2000-08-25 |
December, 2000 | FDA 483 Response | Kindeva Drug Delivery L.P. - Form 483R, 2000-12-20 |
June, 2001 | EIR | Bachem Americas, Inc. - EIR, 2001-06-08 |
August, 2000 | FDA 483 Response | Gilead Sciences, Inc. - Form 483R, 2000-09-12 |
August, 2000 | EIR | Gilead Sciences, Inc. - EIR, 2000-08-25 |
December, 2000 | EIR | Kindeva Drug Delivery L.P. - EIR, 2000-12-13 |
December, 2000 | FDA 483 | Kindeva Drug Delivery L.P. - Form 483, 2000-12-13 |
June, 2001 | FDA 483 | Bachem Americas, Inc. - Form 483, 2001-06-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more